Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Union Carbide Corporation has 5 pending office actions in Biotechnology & Pharmaceuticals. The workload spans 4 distinct examiners and 4 distinct art units, indicating both a meaningful pending docket and distribution across examination groups.
BERRIOS, JENNIFER A is the busiest examiner, with 2 pending matters. That assignment is the largest identified examiner concentration, while the remaining matters require coordination across the other examiner and art-unit assignments.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERRIOS, JENNIFER A | 2 | 37.1% | +49.3% |
| ZHANG SPIERING, DONGXIU | 1 | 41.2% | +65.2% |
| OGDEN JR, NECHOLUS | 1 | 69.7% | +23.7% |
| WERTZ, ASHLEE ELIZABETH | 1 | 52.7% | +35.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546310 | SHAMPOO FORMULATION WITH ENHANCED SILICONE DEPOSITION | ZHANG SPIERING, DONGXIU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261695 | FABRIC CARE COMPOSITION | OGDEN JR, NECHOLUS | 5d overdue |
| 17795127 | HAIR CLEANSING FORMULATION | WERTZ, ASHLEE ELIZABETH | 55d |
| 18546310 | SHAMPOO FORMULATION WITH ENHANCED SILICONE DEPOSITION | ZHANG SPIERING, DONGXIU | — |
| 18264080 | HAIR CONDITIONER FORMULATION | BERRIOS, JENNIFER A | — |
| 18263980 | FORMULATION FOR THE CARE OF DAMAGED HAIR | BERRIOS, JENNIFER A | — |
| Art Unit | Apps |
|---|---|
| 1613 | 2 |
| 1616 | 1 |
| 1761 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546310 | SHAMPOO FORMULATION WITH ENHANCED SILICONE DEPOSITION | ZHANG SPIERING, DONGXIU | 1616 | §103§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18264080 | HAIR CONDITIONER FORMULATION | BERRIOS, JENNIFER A | 1613 | §103DP | Final Rejection | — | Pending | Aug 03, 2023 |
| 18263980 | FORMULATION FOR THE CARE OF DAMAGED HAIR | BERRIOS, JENNIFER A | 1613 | §103DP | Final Rejection | — | Pending | Aug 02, 2023 |
| 18261695 | FABRIC CARE COMPOSITION | OGDEN JR, NECHOLUS | 1761 | §103 | Non-Final OA | 5d overdue | Pending | Jul 17, 2023 |
| 17795127 | HAIR CLEANSING FORMULATION | WERTZ, ASHLEE ELIZABETH | 1612 | §103 | Non-Final OA | 55d | Pending | Jul 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUnion Carbide Corporation has 5 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Jennifer A Berrios has the most, with 2 of Union Carbide Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
